Story thread · 2 reports / 2 sources
New Data Put ADCs on the Map in Relapsed SCLC
medscape.com · 1h
Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class. Medscape Medical News
First report: Significant Survival Boost With Novel ADCs in Relapsed Small-Cell Lung Cancer — medpagetoday.com, 2d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.